{
    "nctId": "NCT02524548",
    "briefTitle": "SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors",
    "officialTitle": "Improving Medication Adherence With Adjuvant Aromatase Inhibitor in Women With Breast Cancer: A Randomised Controlled Trial to Evaluate the Effect of Short Message Service (SMS) Reminder",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Medication Adherence",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 244,
    "primaryOutcomeMeasure": "Medication adherence",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women who have been receiving adjuvant endocrine therapy for at least 1 year, and are continuing to receive adjuvant AI therapy for at least 1 more year.\n2. Have cellular phone that can receive text messages.\n3. Singaporean or permanent resident who is currently residing in Singapore.\n4. Able to give informed consent.\n\nExclusion Criteria:\n\n1. Unable or not willing to comply with study procedures.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}